- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Column 1 | Column 2 | Column 3 | Column 4 |
---|---|---|---|
Substances | Maximum strength | Use, pharmaceutical form or route of administration | Maximum dose and maximum daily dose |
Dextromethorphan Hydrobromide | Internal | (a)In the case of a controlled release preparation: equivalent of 30 mg of Dextromethorphan (MD), equivalent of 75 mg of Dextromethorphan (MDD); (b)in any other case: equivalent of 15 mg of Dextromethorphan (MD), equivalent of 75 mg of Dextromethorphan (MDD). | |
Ibuprofen | Rheumatic and muscular pain, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of cold and influenza: (1) Internal | (1) (a) In the case of a controlled release preparation: 600 mg (MD), 1200 mg (MDD); (b)in any other case: 400 mg (MD), 1200 mg (MDD). | |
(2) 5.0 per cent. | (2) External |
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: